Preferred Label : Congenital myopathy 4a, autosomal dominant;
Symbol : CMYO4A;
CISMeF acronym : CFTD; CFTDM;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : CFTDM; Fiber-type disproportion myopathy, congenital; CAPM1; NEM1; Nemaline myopathy 1; Cap myopathy 1; CFTD; Myopathy, congenital, with fiber-type disproportion;
Description : Congenital fiber-type disproportion (CFTD) myopathy is a genetically heterogeneous
disorder in which there is relative hypotrophy of type 1 muscle fibers compared to
type 2 fibers on skeletal muscle biopsy. However, these findings are not specific
and can be found in many different myopathic and neuropathic conditions. Clarke and
North (2003) stated that the diagnosis of 'congenital fiber-type disproportion' as
a disease entity is one of exclusion. They also suggested that the nonspecific histologic
findings should be termed 'fiber size disproportion,' thus reserving the term CFTD
for those cases in which no secondary cause can be found.;
Inheritance : Autosomal dominant; Autosomal recessive;
Molecular basis : Caused by mutation in the skeletal muscle alpha-1 actin gene (ACTA1, 102610.0011); Caused by mutation in the selenoprotein N, 1 gene (SEPN1, 606210.0008); Caused by mutation in the tropomyosin 3 gene (TPM3, 191030.0005);
Prefixed ID : #255310;
Origin ID : 255310;
UMLS CUI : C0546264;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT